Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Nature
|
June 29, 2018
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
Andrew M Intlekofer, Alan H Shih, Bo Wang, et al.
Blood Advances
|
July 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma
Sean E Healton, Manik Uppal, Pallavi K Galera, et al.
Blood Advances
|
June 12, 2023
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver, Esther Drill, David Qualls, et al.
Nature
|
October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
Akihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J Savage, et al.
Blood Cancer Journal
|
June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Andrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.
Blood Advances
|
April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Blood
|
March 12, 2016
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
Jie He, Omar Abdel-Wahab, Michelle K Nahas, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Nature
|
June 29, 2018
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
Andrew M Intlekofer, Alan H Shih, Bo Wang, et al.
Blood Advances
|
July 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma
Sean E Healton, Manik Uppal, Pallavi K Galera, et al.
Blood Advances
|
June 12, 2023
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver, Esther Drill, David Qualls, et al.
Nature
|
October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
Akihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J Savage, et al.
Blood Cancer Journal
|
June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Andrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.
Blood Advances
|
April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Blood
|
March 12, 2016
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
Jie He, Omar Abdel-Wahab, Michelle K Nahas, et al.
Page
of 6